Introduction

Meso Scale Discovery (MSD) is a third-generation immunoassay technique with an extremely wide detection range from sub-picograms to tens of thousands of picograms and a sensitivity of up to 0.05 pg/ml, enabling effective detection of differences between experimental groups. MSD technology is widely used in the analysis of biomarker and immunogenicity assays. Creative Proteomics has established a platform for the detection of cytokines and other proteins based on MSD technology, which allows for the quantitative analysis of various cytokines, chemokines and other proteins, as well as multi-component assays for up to 10 fractions.

Principle of MSD Analysis

Electrochemiluminescence is a specific chemiluminescence reaction triggered by electrochemistry on the electrode surface. The MSD electrochemiluminescence detection technique uses SULFO-TAGTM markers, which are electrochemically excited to emit intense light when the electrode surfaces of MULTI-ARRAY and MULTI-SPORT microplates are energized.

MSD Assay Service

Advantages of MSD Analysis Technology

Sample Requirements

Samples from humans, mice, rats, primates, pigs, horses, dogs, cats and other species.

Samples available: serum, plasma, culture supernatant, cell/tissue lysate, cerebrospinal fluid, urine, synovial fluid, saliva, sputum, fecal extracts, eye room water, various types of irrigation fluid, and basically all biological samples.

Creative Proteomics can provide you with a one-stop solution for cytokines, chemokines and other proteins detection and quantification through MSD technology. If you would like to use other analytical techniques or inquire about our services, please contact us and we look forward to working with you.

Related Services

Disease Cytokine Assays
Luminex Cytokine Detection Service
Flow Cytometry Cytokine Assay
Human Cytokine Assay
Mouse Cytokine Assay

* For Research Use Only. Do Not use in diagnostic or therapeutic procedures.

Online Inquiry

×

Contact Us

  • Tel:
  • Fax:
  • Email:
  • Address:
Copyright © 2022 Creative Proteomics. All rights reserved.